The need for speed and safety: A primer on the FDA’s drug approval pathways By STATMay 16, 2022 Reprints https://reports.statnews.com/products/speed-and-safety-fdas-drug-approval?utm_source=statnews.com&utm_campaign=primer_report_may22&utm_medium=stat_reports_articlewidget2.0 About the Author Reprints STAT [email protected]
Pharmalot Ed Silverman and Damian Garde STAT Plus: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Special Report Brittany Trang STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
